InvestorsHub Logo
icon url

XenaLives

10/05/19 6:06 PM

#213230 RE: powerwalker #213227

Agreed - and I believe they will approve provisionally on delivery of data for PDD and Rett's because they already have five years of data on Alzheimer's.


The Aussies will not give approval for 2-73 to be given for one disease, or two, or three, ... but ALL CSN diseases as Anavex shows them how 2-73 helps from the "ground up" to remedy the affliction, that it is the same for all CSN diseases by demonstrating where/how the disease begins and how it is attacked by 2-73.

icon url

Gernee20

10/05/19 6:39 PM

#213232 RE: powerwalker #213227

Power, are you projecting an Aussie approval in 2020 for all cns indications?
icon url

jtsmgoblue

10/05/19 6:50 PM

#213233 RE: powerwalker #213227

I like the way you think.

Many thanks to the strategic thinking and proactive Aussies.

And to no surprise, IMO the FDA bureaucracy, insurance companies and BP are squarely to blame for the program delay and the US the missing the opportunity to be the lead country.

icon url

nidan7500

10/05/19 7:03 PM

#213235 RE: powerwalker #213227

powerwalker...

TGD is not going to Australia for a brief presentation. He is there for some very important meetings, too, though, the meeting results might not be disclosed for a few weeks/months.



PW, thanks very much for this insight. I have nothing but the highest regard for the Australians' competence and management capability in working out such a comprehensive national program. With luck other governments will pay attention. The scope and power of this science is difficult to even define, never mind implement. Doubters will be watching as science moves on. thanks very much.
icon url

Jonjones325

10/06/19 4:53 PM

#213315 RE: powerwalker #213227

Can you remind us of why and when Missling is going to Australia?